Creative Medical Technology Holdings, Inc.
CELZ
$1.04
-$0.04-3.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00% | -- | -- |
| Cost of Revenue | -- | -- | -16.67% | -- | -- |
| Gross Profit | -- | -- | 11.11% | -- | -- |
| SG&A Expenses | 47.64% | 0.02% | -1.89% | 55.80% | 8.19% |
| Depreciation & Amortization | -25.41% | -5.56% | 36.73% | 6.14% | 4.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.64% | -12.28% | 3.18% | 14.72% | -22.64% |
| Operating Income | -23.64% | 12.12% | -3.19% | -14.72% | 22.26% |
| Income Before Tax | -22.54% | 14.31% | -1.81% | -18.83% | 20.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.54% | 14.31% | -1.81% | -18.83% | 20.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.60% | 14.22% | -1.81% | -18.83% | 20.83% |
| EBIT | -23.64% | 12.12% | -3.19% | -14.72% | 22.26% |
| EBITDA | -24.85% | 12.25% | -2.77% | -14.96% | 22.76% |
| EPS Basic | 14.52% | 54.10% | 35.42% | 35.90% | 56.89% |
| Normalized Basic EPS | 14.50% | 54.07% | 35.42% | 35.90% | 56.89% |
| EPS Diluted | 14.52% | 54.10% | 35.42% | 35.90% | 56.89% |
| Normalized Diluted EPS | 14.50% | 54.07% | 35.42% | 35.90% | 56.89% |
| Average Basic Shares Outstanding | 43.45% | 86.89% | 57.63% | 85.34% | 83.64% |
| Average Diluted Shares Outstanding | 43.45% | 86.89% | 57.63% | 85.34% | 83.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |